IXHL
NASDAQ · Pharmaceuticals
Incannex Healthcare Inc
$2.85
-0.22 (-7.17%)
Open$2.99
Previous Close$3.07
Day High$3.02
Day Low$2.83
52W High$49.80
52W Low$2.40
Volume—
Avg Volume1.00M
Market Cap37.03M
P/E Ratio—
EPS$-18.65
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 918.3K | 1.73M | 25.07M |
| Net Income | -500,560,904 | -847,132,030 | 4.81M |
| Profit Margin | -54,517.4% | -51,791.6% | 19.2% |
| EBITDA | -492,275,112 | -879,393,298 | 6.46M |
| Free Cash Flow | — | — | 4.01M |
| Rev Growth | -46.8% | -46.8% | +16.3% |
| Debt/Equity | — | — | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |